User login
April 2021: Journal Scans and Expert Commentary
Dr. Vinod Chandran: Holistic management of psoriatic disease should include management of associated comorbidities
- Over half of PsA patients not diagnosed within 2 years of symptom onset
- Agreement between modalities for imaging of finger joints in PsA patients
- Cognitive impairment is a manifestation of PsA
- Intravenous golimumab improves HRQoL and productivity in patients with active PsA
- Depression and anxiety linked to reduced probability of achieving sustained MDA in PsA
- Risk factors for progression from subclinical to clinical psoriatic arthritis
- Continuing ixekizumab superior to withdrawal in stable psoriatic arthritis
- PsA: Brodalumab demonstrates favorable efficacy in phase 3 trials
- Is pain linked to mortality risk in patients with psoriatic arthritis?